BioLineRx (BLRX) Operating Income Growth (5y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.43% |
| Sep 30, 2025 | 13.84% |
| Jun 30, 2025 | 16.18% |
| Mar 31, 2025 | 18.96% |
| Dec 31, 2024 | 14.01% |
| Sep 30, 2024 | 4.10% |
| Jun 30, 2024 | 2.28% |
| Mar 31, 2024 | 2.87% |
| Dec 31, 2023 | -21.41% |
| Sep 30, 2023 | -14.75% |
| Jun 30, 2023 | -11.60% |
| Mar 31, 2023 | -5.96% |
| Dec 31, 2022 | -1.78% |
| Sep 30, 2022 | -0.06% |
| Jun 30, 2022 | -7.92% |
| Mar 31, 2022 | -2.78% |
| Dec 31, 2021 | -8.52% |
| Sep 30, 2021 | -6.73% |
| Jun 30, 2021 | -11.00% |
| Mar 31, 2021 | -7.61% |
| Dec 31, 2020 | -7.45% |
| Sep 30, 2020 | -5.23% |
| Jun 30, 2020 | -5.97% |
| Mar 31, 2020 | -9.59% |
| Dec 31, 2019 | -12.61% |
| Sep 30, 2019 | -10.29% |
| Jun 30, 2019 | -10.62% |
| Mar 31, 2019 | -6.48% |
| Dec 31, 2018 | -25.22% |
| Sep 30, 2018 | -13.66% |
| Jun 30, 2018 | -4.34% |
| Mar 31, 2018 | -0.38% |